COSMOS Pharmaceutical Corporation
CSMYFOTCHealthcare● Active
$41.20
+$4.14(+11.17%)
Market Cap$3.3B
P/E Ratio—
52W High$48.271
52W Low$37.06
COSMOS Pharmaceutical Corporation（CSMYF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSMYF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.011T | $0.965T | $0.828T | $0.755T | $0.726T |
| Cost of Revenue | $0.798T | $0.777T | $0.659T | $0.604T | $0.581T |
| Gross Profit | $0.213T | $0.188T | $0.169T | $0.151T | $0.145T |
| Gross Margin %(computed) | 21.09% | 19.51% | 20.38% | 20.05% | 19.98% |
| Operating Expenses | |||||
| R&D Expenses | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| G&A Expenses | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Total Operating Expenses | $0.173T | $0.157T | $0.139T | $0.122T | $0.112T |
| Operating Income | $0.040T | $0.032T | $0.030T | $0.030T | $0.033T |
| Operating Margin %(computed) | 3.99% | 3.26% | 3.64% | 3.94% | 4.56% |
| Interest Income | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Interest Expense | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Income Before Tax | $0.042T | $0.034T | $0.033T | $0.033T | $0.039T |
| Income Tax Expense | $0.011T | $0.009T | $0.009T | $0.010T | $0.011T |
| Net Income | $0.031T | $0.024T | $0.024T | $0.023T | $0.027T |
| Net Margin %(computed) | 3.06% | 2.53% | 2.88% | 3.07% | 3.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $390.86 | $308.61 | $600.95 | $584.74 | $685.77 |
| Wtd Avg Shares | 0.000T | 0.000T | 0.000T | 0.000T | 0.000T |
| EBITDA | $0.065T | $0.054T | $0.050T | $0.048T | $0.052T |
| EBITDA Margin %(computed) | 6.41% | 5.57% | 6.06% | 6.38% | 7.22% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · JPY · T
深入了解COSMOS Pharmaceutical Corporation
关于COSMOS Pharmaceutical Corporation（CSMYF）损益表
COSMOS Pharmaceutical Corporation（CSMYF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CSMYF实现营收$1011.39B，毛利润$213.28B（毛利率21.09%），净利润$30.98B（净利率3.06%）。
常见问题
CSMYF · 4 问COSMOS Pharmaceutical Corporation（CSMYF）2025财年营收为$1011.39B，同比up4.8%。
CSMYF revenueCSMYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09